MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+7.45%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$17.4B
AUM Growth
+$604M
(+3.6%)
Cap. Flow
-$359M
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
29.23%
Holding
2,954
New
46
Increased
346
Reduced
1,409
Closed
76
Top Buys
| 1 |
Apple
AAPL
|
+$19.3M |
| 2 |
Palantir
PLTR
|
+$18.1M |
| 3 |
Avantor
AVTR
|
+$8.78M |
| 4 |
Dell
DELL
|
+$8.32M |
| 5 |
Broadcom
AVGO
|
+$6.78M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$43.9M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$25.3M |
| 3 |
NVIDIA
NVDA
|
+$25.3M |
| 4 |
Microsoft
MSFT
|
+$24.1M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$12.3M |
Sector Composition
| 1 | Technology | 29.87% |
| 2 | Financials | 12.38% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHCT
2076
Community Healthcare Trust
CHCT
$440M
| $293K | ﹤0.01% |
16,140
+13
| +0.1% | +$236 |
|
2077
Phibro Animal Health
PAHC
$1.67B
| $293K | ﹤0.01% |
12,996
| – | – |
|
2078
National CineMedia
NCMI
$423M
| $292K | ﹤0.01% |
+41,472
| New | +$292K |
|
|
RVNC
2079
DELISTED
Revance Therapeutics, Inc.
RVNC
| $292K | ﹤0.01% |
56,279
+1,010
| +2% | +$5.24K |
|
2080
Republic Bancorp
RBCAA
$1.49B
| $292K | ﹤0.01% |
4,469
-631
| -12% | -$41.2K |
|
2081
Y-mAbs Therapeutics
YMAB
$390M
| $291K | ﹤0.01% |
22,141
| – | – |
|
|
BFS
2082
Saul Centers
BFS
$779M
| $290K | ﹤0.01% |
6,900
-210
| -3% | -$8.81K |
|
|
OLP
2083
One Liberty Properties
OLP
$492M
| $289K | ﹤0.01% |
10,478
-16
| -0.2% | -$441 |
|
2084
CorMedix
CRMD
$955M
| $288K | ﹤0.01% |
35,639
| – | – |
|
2085
Pagaya Technologies
PGY
$2.83B
| $288K | ﹤0.01% |
27,232
+16,804
| +161% | +$178K |
|
2086
Build-A-Bear
BBW
$962M
| $287K | ﹤0.01% |
8,360
| – | – |
|
2087
i3 Verticals
IIIV
$720M
| $287K | ﹤0.01% |
13,472
| – | – |
|
2088
NewtekOne
NEWT
$305M
| $287K | ﹤0.01% |
23,035
| – | – |
|
2089
Tyra Biosciences
TYRA
$635M
| $287K | ﹤0.01% |
12,207
| – | – |
|
2090
Myers Industries
MYE
$602M
| $287K | ﹤0.01% |
20,731
| – | – |
|
2091
Terns Pharmaceuticals
TERN
$654M
| $286K | ﹤0.01% |
34,260
| – | – |
|
|
NLOP
2092
Net Lease Office Properties
NLOP
$432M
| $286K | ﹤0.01% |
9,327
+5,000
| +116% | +$153K |
|
2093
Dine Brands
DIN
$361M
| $286K | ﹤0.01% |
9,144
| – | – |
|
2094
Regenxbio
RGNX
$483M
| $285K | ﹤0.01% |
27,189
| – | – |
|
2095
Humacyte
HUMA
$234M
| $284K | ﹤0.01% |
52,295
| – | – |
|
2096
Savara
SVRA
$662M
| $284K | ﹤0.01% |
66,907
+14,883
| +29% | +$63.1K |
|
2097
Leslie's
LESL
$62M
| $284K | ﹤0.01% |
89,716
-14,336
| -14% | -$45.3K |
|
2098
Columbia Financial
CLBK
$1.6B
| $283K | ﹤0.01% |
16,597
| – | – |
|
2099
Erasca
ERAS
$440M
| $283K | ﹤0.01% |
103,686
+35,355
| +52% | +$96.5K |
|
2100
Olema Pharmaceuticals
OLMA
$536M
| $283K | ﹤0.01% |
23,695
| – | – |
|